FEMYFemasys Inc. Common Stock
Femasys Inc., a biomedical company, develops and commercializes therapeutic and diagnostic products for women's reproductive health needs in the United States and internationally. The company offers FemaSeed, an intratub…
Industry Peers
Medical Instruments & Supplies| Headline | Source | Time |
|---|---|---|
Older | ||
 Femasys Secures FDA Pathway for Non-Surgical Contraceptive The U.S. Food and Drug Administration (FDA) on Wednesday authorized the modular premarket approval application pathway for FemBloc, a non-surgical permanent birth control technology. Femasys Inc. (NASDAQ:FEMY) announced the regulatory milestone for its investigational contraceptive device. Office-Based Alternative To Surgical Sterilization FemBloc represents a first-of-its-kind permanent birth control option designed specifically for delivery within a standard OB/GYN office setting. During the p | ||
 FEMY Stock Rallies On Key Regulatory Milestone For Investigational Birth Control Technology – Retail Sees 500% Upside Potential The U.S. Food and Drug Administration accepted Femasys’ modular premarket approval application for FemBloc, an experimental non-surgical permanent birth control technology. | ||
 Femasys Secures FDA Approval for Modular PMA Pathway for FemBloc Femasys has received FDA approval to use a modular premarket approval submission process for FemBloc, giving the company a defined regulatory framework as its pivotal U. S. | ||